Stay updated on Margetuximab Pembrolizumab Combo in HER2(+) Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Margetuximab Pembrolizumab Combo in HER2(+) Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Margetuximab Pembrolizumab Combo in HER2(+) Gastric Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Difference
    0.2%
    Check dated 2025-05-08T13:50:00.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T06:17:08.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2025-04-24T01:01:32.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The web page has undergone significant content removal, particularly regarding the detailed description of a clinical study on margetuximab and pembrolizumab for treating HER2+ gastric and gastroesophageal junction cancer, which is crucial for understanding the study's purpose and criteria.
    Difference
    17%
    Check dated 2025-04-16T20:30:20.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for March 17, 2025, while a date for March 25, 2025, has been removed.
    Difference
    0.2%
    Check dated 2025-04-09T14:09:33.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version (v2.14.3) and a more recent last update date of March 25, 2025, replacing the previous version (v2.14.2) and date of March 17, 2025.
    Difference
    0.2%
    Check dated 2025-04-02T00:09:21.000Z thumbnail image

Stay in the know with updates to Margetuximab Pembrolizumab Combo in HER2(+) Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Margetuximab Pembrolizumab Combo in HER2(+) Gastric Cancer Clinical Trial page.